Microbiotica Funding: $73M Raised, Series B (2022)
Microbiotica is based in Cambridge, United Kingdom. It has raised $73M in total funding. Latest round: Series B.
Microbiotica funding overview
Microbiotica is based in Cambridge, United Kingdom. Microbiotica has raised $73M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in March 2022. The round record for Microbiotica runs through 2022; nothing later has been disclosed. Investors on record include Cambridge Innovation Capital, IP Group, British Patient Capital, Flerie Invest, Seventure Partners, Tencent and 1 others. 7 distinct backers are named across the disclosed rounds.
Microbiotica at a glance
Total raised
$73M
Latest round
Series B
Latest round date
March 2022
Headquarters
Cambridge, United Kingdom
Notable investors
Cambridge Innovation Capital, IP Group, British Patient Capital, Flerie Invest, Seventure Partners, Tencent, British Patient Capital
Frequently asked about Microbiotica funding
How much has Microbiotica raised?
Microbiotica has raised $73M in total disclosed funding across the rounds on record.
Who has invested in Microbiotica?
Cambridge Innovation Capital, IP Group, British Patient Capital, Flerie Invest, Seventure Partners, Tencent are named among the investors backing Microbiotica.
What was the latest Microbiotica funding round?
The most recent disclosed round is a Series B, announced in March 2022.
Where is Microbiotica based?
Microbiotica is based in Cambridge, United Kingdom.
When did Microbiotica last raise?
The last disclosed Microbiotica round closed in March 2022 at Series B.
Microbiotica totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
